drugset / Trial / NCT02094651

Treatment of Children With Autism Spectrum Disorders and Epileptiform EEG With Divalproex Sodium

NCT02094651 ↗

RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to determine if treatment of epileptiform abnormalities in children with autism spectrum disorder will improve any behaviors in these children. The investigators will study a number of different behavioral outcomes including behaviors related to attention, social communication, repetitive behaviors, maladaptive behaviors, language, motor and sensory, and sleep. The investigators will use an anticonvulsant medication called valproic acid (in the form of sodium divalproex).

Timeline

Start
2014-04
Primary completion
2016-10
Completion
2016-10

Outcome

Outcome not reported

Stopped (Enrollment): “No eligible patients were enrolled”

Drugs

EvaluationDrugModalityDoseRoute
Subject Divalproex Sodium Small molecule 30 mg/kg —